Initiators of rivaroxaban or warfarin vs apixaban have significantly higher rates of major hemorrhage. HealthDay News — For patients with cirrhosis and nonvalvular atrial fibrillation (AF), initiators ...

For patients with HIV and atrial fibrillation, this study found that apixaban was associated with less bleeding when compared with warfarin and rivaroxaban. Data remain inconclusive regarding ...

In the absence of head-to-head trials, real-world data may help inform treatment decisions. Rates of major bleeding are lower with apixaban compared with rivaroxaban or warfarin in patients with ...

When diagnosed with a blood clot or atrial fibrillation, patients are often prescribed anticoagulants, or blood thinners, to prevent a future clot. In a study of the three most commonly prescribed ...

In addition to the apixaban cohort, this analysis of the U.S. Medicare database included cohorts comparing two other direct oral anticoagulants (rivaroxaban and dabigatran) separately with warfarin.

In an editorial, one expert said the choice of DOAC in VTE is “no longer a toss-up,” with apixaban the clear winner.

Modern blood-thinning drugs (known as NOACs) reduce the risk of serious bleeding by up to 45 percent compared to the traditional drug warfarin in the treatment of blood clots in the legs and lungs, ...